| ||
| What's next for the US healthcare law? Reuters By Donna Smith If the court does decide that the coverage mandate violates the Constitution, many experts believe the judges would most likely strike down just that provision and leave the rest of the law intact. A decision striking down the purchase ... See all stories on this topic » | ||
| ||
| ||
| Gilead HIV drug as effective as Merck drug in trial Reuters By Toni Clarke BOSTON (Reuters) - Gilead Sciences Inc said on Wednesday that its experimental HIV drug elvitegravir proved as effective as a drug made by Merck & Co in a late-stage clinical trial. The trial showed that after 48 weeks of treatment, ... See all stories on this topic » | ||
| Well: What's Your Biggest Regret? New York Times (blog) By TARA PARKER-POPE We all have regrets, but new research suggests the most common regret among American adults involves a lost romantic opportunity. Researchers at Northwestern University and the University of Illinois at Urbana-Champaign collected ... See all stories on this topic » | ||
| Factbox: Lawsuits challenging healthcare reform Reuters (Reuters) - More than half of all states have launched lawsuits challenging the constitutionality of the healthcare reforms signed into law by President Barack Obama a year ago. Most legal scholars expect one of the suits to reach the US Supreme Court. ... See all stories on this topic » | ||
| WHO Report Urges Countries To Step Up Fight Against Drug-Resistant TB Kaiser Family Foundation A WHO report released Wednesday says countries with the highest drug-resistant tuberculosis burdens are making progress in addressing the disease, "but despite the recent scale up in efforts, the world needs to do much more to get care to all ... See all stories on this topic » | ||
| Cosmetic procedures slowly making a comeback, nationally and locally KSBY San Luis Obispo News If you find yourself with some extra cash and start to think about spending it on a cosmetic procedure you are not alone. Cosmetic procedures have long been a good economic indicator. Many experts have said we are experiencing a slight up turn in the ... See all stories on this topic » | ||
| Product recalls: Delta drop-side cribs and Gerber Gator combo axe Washington Post By AP, Wednesday, March 23, 10:53 AM DETAILS: The Consumer Product Safety Commission reissued a 2008 recall of more than 985000 drop-side cribs by Delta Enterprise Corp., in New York, because of the death of a 7-month-old girl from Colorado Springs, ... See all stories on this topic » | ||
| ||
| Venezuela's Confirmed Swine Flu Cases Climbs To 100 Wall Street Journal By Ezequiel Minaya CARACAS (Dow Jones)--The number of confirmed H1N1 flu cases in Venezuela has risen to 100, the country's health minister, Eugenia Sader, said Tuesday. Speaking on state television, Sader assured Venezuelans with estimates that fewer ... See all stories on this topic » | ||
| High school student uses disease to inform others WALB-TV By Laura Ann Sills - bio | email COLUMBUS, GA - Nearly twenty-million people in the United States have diabetes. But, even more shocking, there are another seven-million that do not know yet. Chelsea Walker found out she was a Type 1 diabetic at the ... See all stories on this topic » | ||
| Broncos Crack the Top 10 in National Polls WMUBroncos.com KALAMAZOO -- Heading in to their first bid in the NCAA Tournament since 1996, the Western Michigan Bronco hockey team has reached its highest ranking in both the USCHO.com and USA Today/USA Hockey Magazine Poll since the 2000-01 season, placing 10th in ... See all stories on this topic » | ||
| GSK scraps plans to market prostate-cancer drug Seattle Post Intelligencer AP LONDON -- Drug giant GlaxoSmithKline PLC says it will no longer pursue global regulatory approval to market its Avodart drug to treat prostate cancer following negative feedback from American and Swedish regulators. Avodart is approved in more than ... See all stories on this topic » | ||
| Experts: Stem cell research ban could make criminals out of patients Minnesota Independent By Andy Birkey | 03.23.11 | 10:55 am A bill in the Minnesota Legislature that would ban some forms of stem cell research could have unintended consequences for patients and researchers if it becomes law. The Human Cloning Prohibition Act could cost the ... See all stories on this topic » | ||
| FDA Extends Review of Novartis Lung Drug Wall Street Journal By GORAN MIJUK Chances for a quick approval of Novartis AG's lung drug indacaterol have been quashed by the US Food and Drug Administration, which alerted the Swiss pharma giant it needs three more months to assess the medicine's trial data. ... See all stories on this topic » | ||
| HP to Extend Health Care Zacks.com Hewlett-Packard Company (HPQ - Analyst Report) recently signed a 5-year deal with the health care division of Nevada Department of Health and Human Services. Per the terms of the deal, HP will receive a sum of $176.0 million. Nevada Division of Health ... See all stories on this topic » | ||
| 23000 Pounds of Bologna Recalled Over E. Coli Food Product Design WASHINGTON—Palmyra Bologna Co. Inc., a Palmyra, Pa., firm, is recalling approximately 23000 pounds of Lebanon bologna products because they may be contaminated with E. coli O157:H7, USDA's Food Safety and Inspection Service (FSIS) announced March 22. ... See all stories on this topic » | ||
| Colorado reporting 'miniscule' radiation from Japan reactor The Coloradoan Colorado has joined other states now reporting detection of minuscule levels of radiation coming from the Fukushima nuclear power plant in Japan, according to state health officials. Preliminary sampling from a Denver monitor has detected a radioactive ... See all stories on this topic » |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment